Tustin, California, July 11, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global leader in innovative diagnostic imaging technology, today announces it has signed a definitive agreement to acquire NXC Imaging, a medical imaging equipment distributor and service provider […]
Financial
Story Health Appoints Cardiovascular Changemaker Andrew Sauer, MD to Advisory Board
Renowned Cardiologist and Innovator Brings Unparalleled Expertise to Story Health and Fuels Mission of Transforming Care for Americans with Heart Failure SAN JOSE, Calif.–(BUSINESS WIRE)–Story Health, a health technology and services company that extends specialty care to patients’ homes, today announced the appointment of Dr. Andrew Sauer to its Board […]
AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance
Fiscal Year 2022 Fourth Quarter Highlights Net sales of $87.0 million increased 13.2% compared to the prior-year quarter Gross margin of 53.4% declined 170 basis points year over year GAAP loss per share of $0.16 and adjusted earnings per share of $0.01 Cash and cash equivalents at May 31, 2022 […]
Artio Medical Welcomes Experienced Human Resources Leader
Prairie Village, KS – July 12, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Emily Holliday has joined the company as Vice President of Human Resources. A seasoned executive with over 20 years of human […]
Rebecca Cogswell, MD, Named Incoming Medical Director of the International Thoracic Organ Transplant Registry International Society for Heart and Lung Transplantation (PRNewsfoto/The International Society of Heart and Lung Transplantation)
CHICAGO, July 11, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) named Rebecca Cogswell, MD, the Medical Director of the Society’s International Thoracic Organ Transplant (TTX) Registry. The search process was led by the ISHLT Research Oversight Committee, chaired by Jason Christie, MD, MS. Dr. Cogswell is Associate Professor of Medicine, […]
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of June 30, 2022
PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today discloses the total number of voting rights and shares as of June 30, 2022 (pursuant to Article L. 233-8 II of the French Commercial […]
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) — OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare systems BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater […]
VESTECK, Inc. Continues to Expand Scientific Advisory Board
WEST CHESTER, Pa., July 5, 2022 /PRNewswire/ — VESTECK, Inc. Expands the Scientific Advisory Board to include an international luminary in complex aortic repair, Dr. Sukgu Han. VESTECK is pleased to announce that Dr. Sukgu Han has graciously agreed to join the VESTECK Scientific Advisory Board. Dr. Han is the Co-Director of the Comprehensive Aortic […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., July 05, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 30, 2022 it granted stock options to purchase an aggregate of 180,450 shares of common stock to 19 new employees, whose employment commenced in June 2022, as a material inducement to […]
Ambrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointments of Edward Hu and Kate Hermans to its Board of Directors. “I am delighted to welcome both Edward and […]



